Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kudzu resistant starch
- Development stage
- Preclinical
- Modality
- Microbiome Therapeutics
- Administration
- Oral
01
Overview
Kudzu resistant starch (KRS) is a dietary supplement and prebiotic derived from the kudzu plant (*Pueraria lobata*). It is characterized by its resistance to digestion in the small intestine, allowing it to reach the colon where it undergoes fermentation by gut microbiota. KRS has demonstrated therapeutic potential in metabolic disorders, including non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). Its mechanism involves the modulation of gut microbiota diversity, enhancement of intestinal barrier function (via increased expression of zonula occludens-1 and mucin 2), and suppression of systemic inflammation through the down-regulation of the LPS/TLR4 signaling pathway. Additionally, KRS regulates lipid metabolism and improves insulin sensitivity by modulating signaling pathways such as IRS-1/PI3K/AKT/Glut4 and PPAR-γ.
- Other names
- kudzu-resistant starchKRS
02
Targets
FFAR2SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)IRS1 (Insulin receptor substrate 1)PPARG (Peroxisome proliferator-activated receptor gamma)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)TJP1 (Tight junction protein 1 (ZO-1))TLR4 (Toll-like receptor 4)SREBP-1 / SREBF1 (SREBP-1)
Beyond the preview
Go deeper on kudzu resistant starch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kudzu resistant starch.